$QNT

SHARAN NITESH purchased $390K of QNT

SHARAN NITESH (Chief Financial Officer) purchased 6,500 shares of Quantinuum Inc. (QNT) at $60.00 ($0.39M total) on 2026-06-05.

Original reporting
SEC EDGAR · SHARAN NITESH
Published Jun 8, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QNT
Bullish
medium confidence
Mentioned
$QNT
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QNTBullishLow
01

Why it matters

The newest fact is the CFO’s open-market purchase (~$390K) and the absence of a pre-arranged 10b5-1 plan, which can slightly increase perceived conviction.

02

Market read

Traders may treat the filing as a small sentiment input, but it does not provide new financial guidance, contracts, or regulatory outcomes.

03

What to watch

Check whether there are concurrent insider sales/option exercises and whether the company has upcoming earnings or guidance events that would better explain positioning.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-08; transaction dated 2026-06-05

Background

The article is an SEC Form 4 insider transaction disclosure for Quantinuum (QNT).

Company-level read

Ticker impact

$QNTBullishMedium confidence
Context

CFO Sharan Nitesh filed an open-market purchase of 6,500 QNT shares for ~$390K on 2026-06-05 (Form 4).

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and should fade without additional company news.

Evidence & confidence

The disclosure is a routine Form 4 insider transaction with no 10b5-1 plan and no accompanying operational/financial update.

Market effects

Minimal; this is company-specific insider activity with no sector-wide datapoint.

None indicated.

None indicated.

Counterpoint

Insider buys can be discretionary and may not reflect near-term fundamentals; without a 10b5-1 plan, timing could be personal liquidity-driven.

Key entities

  • Quantinuum Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Sharan Nitesh

    Chief Financial Officer who purchased 6,500 shares of QNT.

Related articles

$HONMed

Honeywell (NASDAQ: HON) Q2 2026 profit surges on Quantinuum gain

Honeywell (HON) amended its Q2 2026 report to correct segment backlog presentation. It said Q2 and YTD 2026 net sales rose 4% and 3%. Profit was boosted by a $6,629 million gain from Quantinuum deconsolidation, while backlog rose 12% to $38,008 million. The filing also cites margin pressure, $311 million impairments, and a $241 million debt-extinguishment loss.

$QNTMed

Why Is Quantinuum Stock Surging On Thursday? - Quantinuum (NASDAQ:QNT)

Quantinuum (NASDAQ:QNT) shares rose 6.37% to $54.67 Thursday as traders bought after the stock rebounded from its IPO floor. The company, based in Broomfield, Colorado, said it priced an upsized IPO of 28,000,000 Class A shares at $60 each, raising $1.68 billion in gross proceeds, and it cited ongoing commercialization and customer engagements across multiple sectors.